New insight from the interplay between nitric oxide and glucocorticoids.
Suzuki
Hisanori
H
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000276:immunology / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods / Q000592:standards; D003907:Dexamethasone / Q000276:immunology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005938:Glucocorticoids / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation; D019001:Nitric Oxide Synthase / Q000187:drug effects / Q000502:physiology; D052247:Nitric Oxide Synthase Type II; D051381:Rats; D012772:Shock, Septic / Q000188:drug therapy* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D003907:Dexamethasone; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat